Dr. Joslyn is the Chief Executive Officer of Edusa Pharmaceuticals. He previously served as the President and Chief Executive Officer of Mt Cook Pharma, a company focused on the development of products to treat urologic disorders. Previously, Dr. Joslyn served as Senior Vice President of Research & Development at Penwest Pharmaceuticals where he led the firm’s efforts in transitioning from a drug delivery company to a specialty pharmaceutical company developing treatments for nervous system disorders. From 1995 to 2004, Dr. Joslyn held a number of leadership positions within Johnson & Johnson, primarily focusing on the development of Gastroenterology products including Propulsid®, Motilium®, Aciphex® and prucalopride. Prior to joining Johnson & Johnson, Dr. Joslyn was a director of clinical research at the Glaxo Research Institute from 1988 to 1995.

Dr. Joslyn received his B.S. in Medicinal Chemistry, B.A. in Biology and Ph.D. in Biochemical Pharmacology from the State University of New York at Buffalo.